Acino Holding Ltd Accepts $439 Million Takeover Offer

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Swiss generic drugmaker Acino (ACIN.S) said it has accepted a takeover offer from Avista Capital Partners and Nordic Capital valuing the company at about 398 million Swiss francs ($439 million). The private equity companies will offer 115 Swiss francs per share representing a 33 percent premium to Tuesday’s closing share price of 86.50 francs, Acino said in a statement. The company’s board unanimously supports the tender offer.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC